Taken together, these results clearly show that our most efficacious Mnk1/2 degrader, VNLG-152R exerts remarkable anti-tumor and anti-metastatic effects in in vivo TNBC models via inhibiting Mnk-eIF4E and mTORC1 signaling without any significant toxicity. This evidence concerns the gene EIF4E and neoplasm.